![Paul da Silva Jardine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul da Silva Jardine was the founder of Staten Biotechnology BV, which he founded in 2014 and where he held the title of Chief Scientific Officer.
He is currently the Chief Scientific Officer & Director at Aethon Therapeutics, Inc.
| Sociétés | Poste | Début |
|---|---|---|
Aethon Therapeutics, Inc.
 Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Staten Biotechnology BV
 Staten Biotechnology BV BiotechnologyHealth Technology Develops novel therapies | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Staten Biotechnology BV
Staten Biotechnology BV BiotechnologyHealth Technology Develops novel therapies | Health Technology |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
